SVB Wealth LLC bought a new position in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 5,330 shares of the company's stock, valued at approximately $417,000.
Other hedge funds and other institutional investors have also made changes to their positions in the company. Cherry Creek Investment Advisors Inc. increased its position in shares of GE HealthCare Technologies by 0.3% in the fourth quarter. Cherry Creek Investment Advisors Inc. now owns 37,351 shares of the company's stock worth $2,920,000 after acquiring an additional 114 shares in the last quarter. Independence Bank of Kentucky increased its position in shares of GE HealthCare Technologies by 6.0% in the fourth quarter. Independence Bank of Kentucky now owns 2,018 shares of the company's stock worth $158,000 after acquiring an additional 114 shares in the last quarter. Tandem Capital Management Corp ADV increased its position in shares of GE HealthCare Technologies by 0.4% in the fourth quarter. Tandem Capital Management Corp ADV now owns 28,210 shares of the company's stock worth $2,205,000 after acquiring an additional 118 shares in the last quarter. Arcus Capital Partners LLC increased its position in shares of GE HealthCare Technologies by 3.0% in the fourth quarter. Arcus Capital Partners LLC now owns 4,113 shares of the company's stock worth $322,000 after acquiring an additional 119 shares in the last quarter. Finally, Custom Index Systems LLC increased its position in shares of GE HealthCare Technologies by 4.4% in the fourth quarter. Custom Index Systems LLC now owns 2,843 shares of the company's stock worth $222,000 after acquiring an additional 120 shares in the last quarter. 82.06% of the stock is currently owned by institutional investors.
GE HealthCare Technologies Stock Up 1.4 %
NASDAQ GEHC traded up $1.17 during trading on Friday, reaching $86.58. The company's stock had a trading volume of 4,075,712 shares, compared to its average volume of 2,984,066. The company has a current ratio of 1.04, a quick ratio of 0.83 and a debt-to-equity ratio of 0.88. The stock has a market capitalization of $39.59 billion, a PE ratio of 20.00, a PEG ratio of 3.19 and a beta of 1.13. The business has a 50-day moving average price of $86.63 and a 200-day moving average price of $86.13. GE HealthCare Technologies Inc. has a 1-year low of $74.51 and a 1-year high of $94.80.
GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last posted its earnings results on Thursday, February 13th. The company reported $1.45 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.26 by $0.19. The firm had revenue of $5.32 billion during the quarter, compared to analysts' expectations of $5.33 billion. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. On average, research analysts forecast that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.
Analyst Ratings Changes
Several research firms have recently weighed in on GEHC. Jefferies Financial Group raised shares of GE HealthCare Technologies from a "hold" rating to a "buy" rating and lifted their target price for the stock from $95.00 to $103.00 in a research report on Wednesday, January 8th. Citigroup boosted their price objective on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the company a "buy" rating in a research report on Thursday, February 13th. Finally, Wells Fargo & Company boosted their price objective on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the company an "overweight" rating in a research report on Friday, February 14th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, eight have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $97.67.
Read Our Latest Stock Report on GE HealthCare Technologies
GE HealthCare Technologies Company Profile
(
Free Report)
GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.
Recommended Stories
Before you consider GE HealthCare Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and GE HealthCare Technologies wasn't on the list.
While GE HealthCare Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
